In: Anatomy and Physiology
A pharmaceutical company has developed a new weight loss drug for women. Preliminary tests show that the drug seems to be fairly effective in about 75% of test subjects. The drug company thinks that the drug might be most effective in overweight women, but they are unsure to whom they should market the product.
Data Table 1 Below:
Weight loss study |
1) Ask a question |
|
2) Research what is already known |
||
3) Create a hypothesis |
||
4) Test the hypothesis |
Question :-
Answer
1) Ask a question | This study was attempted to decide if corpulence is related with obstetric confusions and cesarean delivery. |
2)Research what is already known | Study of 500,000 individuals clears up the dangers of
heftiness. Outline: While it is now realized that extreme weight expands the overall danger of death, past examinations have created clashing outcomes with some seeming to recommend a defensive impact at various parts of the range of weight list |
3)Create a hypothesis | A large prospective multicenter database was studied. Subjects were divided into 3 groups: body mass index (BMI) less than 30 (control), 30 to 34.9 (obese), and 35 or greater (morbidly obese). Groups were compared by using univariate and multivariable logistic regression analyses. |
4)Test the hypothesis | The study included 16,102 patients: 3,752 control, 1,473 large, and 877 beefy beyond belief patients. Heftiness and bleak corpulence had a factually noteworthy relationship with gestational hypertension (chances proportions [ORs] 2.5 and 3.2), preeclampsia (ORs 1.6 and 3.3), gestational diabetes (ORs 2.6 and 4.0), and fetal birth weight more noteworthy than 4000 g (ORs 1.7 and 1.9) and more prominent than 4500 g (ORs 2.0 and 2.4). For nulliparous patients, the cesarean conveyance rate was 20.7% for the control gathering, 33.8% for stout, and 47.4% for very big boned patients. |
Hope you like the answer.
Cheers!!!